Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

207 recalls, newest first

Class II · Moderate risk

Ohm Hand Sanitizer

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Terminated cGMP deviation Urban Electric Power D-0263-2023
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.

Ongoing cGMP deviation Fisher Scientific Co., LLC D-0164-2023
Class II · Moderate risk

Hand Sanitizer

CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.

Ongoing cGMP deviation Fisher Scientific Co., LLC D-0163-2023
Class II · Moderate risk

Sterile Water for Injection

CGMP Deviations: potential for trace amounts of product carryover.

Terminated cGMP deviation Nephron Sc Inc NDC 0487-6105-01 D-0178-2023
Class II · Moderate risk

Humatrix Microclysmic Gel

CGMP Deviations: initiated due to violations of CGMP manufacturing practices

Ongoing cGMP deviation Consolidated Chemical, Inc D-0326-2023

Recalls by year